FTV Stock Analysis: Fortive | NYSE

Scientific & Technical Instruments | NYSE, USA | Market Cap: 20.216m USD | 12M Return: 30.3% | US34959J1088 | Charts, Fundamentals & Technical Analysis

Instrumentation, Sterilization, Radiation Detection, Compliance Software
Total Rating 68
Safety 82
Buy Signal 0.97
Industrial Machinery & Supplies & Components
Sub-Industry Rotation: -1.3
Market Cap: 20.2B
Avg Turnover: 207M
Risk 3d forecast
Volatility27.4%
VaR 5th Pctl4.56%
VaR vs Median1.12%
Reward TTM
Sharpe Ratio0.95
Rel. Str. IBD83.4
Rel. Str. Peer Group84.2 pctl
Character TTM
Beta0.811
Beta Downside0.844
Hurst Exponent0.418
Choppyness40.0%
Drawdowns 3y
Max DD28.03%
CAGR/Max DD0.33
CAGR/Mean DD0.78
EPS (Earnings per Share) EPS (Earnings per Share) of FTV over the last years for every Quarter: "2021-09": 0.66, "2021-12": 0.79, "2022-03": 0.7, "2022-06": 0.78, "2022-09": 0.79, "2022-12": 0.88, "2023-03": 0.75, "2023-06": 0.85, "2023-09": 0.85, "2023-12": 0.98, "2024-03": 0.83, "2024-06": 0.93, "2024-09": 0.97, "2024-12": 1.17, "2025-03": 0.85, "2025-06": 0.58, "2025-09": 0.68, "2025-12": 0.9, "2026-03": 0.7, "2026-06": 0.74, "2026-09": 0.77,
EPS CAGR: -7.64%
EPS Trend: -68.2%
Last SUE: 1.86
Qual. Beats: 1
Revenue Revenue of FTV over the last years for every Quarter: 2021-09: 1301, 2021-12: 1374.8, 2022-03: 1376.5, 2022-06: 1463.3, 2022-09: 1456, 2022-12: 1529.9, 2023-03: 1460.7, 2023-06: 1526.4, 2023-09: 1494.5, 2023-12: 1583.7, 2024-03: 1524.5, 2024-06: 1552.4, 2024-09: 1534.6, 2024-12: 1620.3, 2025-03: 1474.2, 2025-06: 1518.8, 2025-09: 1027.099999, 2025-12: 1122.5, 2026-03: 1069.4, 2026-06: 1096.8, 2026-09: 1107.5,
Rev. CAGR: -12.77%
Rev. Trend: -86.1%
Last SUE: 0.10
Qual. Beats: 0

Warnings

Below Avwap Earnings

Tailwinds

Supp Ema20
Idiosyncratic Leader
Confidence

Seasonality 10.3 years of data, until 10/2026

Jan +1.4% 4
Feb -1.0% 4
Mar -1.2% 15
Apr -1.4% 4
May -0.8% 0
Jun +1.4% 0
Jul +0.6% 0
Aug -0.1% 0
Sep -2.4% 9
Oct +0.8% 0
Nov +5.1% 55
Dec -2.3% 4

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: FTV Fortive

Fortive Corporation (NYSE: FTV) is an Everett, Washington-based industrial and healthcare technology company that was incorporated in 2015 and spun off from Danaher Corporation in July 2016. The company operates two main segments: Intelligent Operating Solutions, which provides instrumentation, software, and services for asset lifecycle management, condition monitoring, and worker safety across manufacturing, utilities, and other industrial end-markets (brands include Fluke, Industrial Scientific, Accruent, and ServiceChannel); and Advanced Healthcare Solutions, which supplies sterilization, instrument tracking, biomedical testing, radiation monitoring, and clinical workflow software (brands include ASP, Fluke Biomedical, Censis, Landauer, and Provation). As a constituent of the Industrials sector, Fortive follows a multi-brand, decentralized operating model that combines recurring software and services revenue streams with hardware-based measurement and safety products.

Headlines to Watch Out For
  • Intelligent Operating Solutions margin expansion drives earnings beats
  • Healthcare Solutions acquisition pipeline accelerates post-Vontier separation
  • China industrial demand weakness pressures test and measurement revenue
Piotroski VR-10 (Strict) 6.5
Net Income: 651.9m TTM > 0 and > 6% of Revenue
FCF/TA: 0.09 > 0.02 and ΔFCF/TA -0.00 > 1.0
NWC/Revenue: 6.61% < 20% (prev -13.08%; Δ 19.69% < -1%)
CFO/TA 0.10 > 3% & CFO 1.20b > Net Income 651.9m
Net Debt (3.24b) to EBITDA (1.32b): 2.44 < 3
Current Ratio: 1.23 > 1.5 & < 3
Outstanding Shares: last quarter (303.9m) vs 12m ago -8.85% < -2%
Gross Margin: 63.47% > 18% (prev 60.33%; Δ 3.14% > 0.5%)
Asset Turnover: 37.59% > 50% (prev 47.45%; Δ -9.86% > 0%)
Interest Coverage Ratio: 6.39 > 6 (EBIT TTM 874.2m / Interest Expense TTM 136.8m)
Altman Z'' 3.45
A: 0.03 (Total Current Assets 1.58b - Total Current Liabilities 1.29b) / Total Assets 11.5b
B: 0.51 (Retained Earnings 5.84b / Total Assets 11.5b)
C: 0.07 (EBIT TTM 874.2m / Avg Total Assets 11.7b)
D: 1.07 (Book Value of Equity 5.95b / Total Liabilities 5.55b)
Altman-Z'' = 3.45 = A
Beneish M -3.15
DSRI: 1.10 (Receivables 669.5m/783.6m, Revenue 4.40b/5.64b)
GMI: 0.95 (GM 60.33% / 63.47%)
AQI: 1.01 (AQ_t 0.84 / AQ_t-1 0.83)
SGI: 0.78 (Revenue 4.40b / 5.64b)
TATA: -0.05 (NI 651.9m - CFO 1.20b) / TA 11.5b)
Beneish M = -3.15 (Cap -4..+1) = AA
What is the price of FTV shares?

As of November 20, 2026, the stock is trading at USD 65.41 with a total of 2,698,590 shares traded. Over the past week, the price has changed by -3.60%, over one month by +13.80%, over three months by +11.19% and over the past year by +30.31%.

Current recommended Stop Loss: 62.10 (which is 5.1% or 2.1 ATR below the current price).

Is FTV a buy, sell or hold?

Fortive has received a consensus analysts rating of 3.25. Therefore, it is recommended to hold FTV.

  • StrongBuy: 3
  • Buy: 1
  • Hold: 10
  • Sell: 1
  • StrongSell: 1

What are the forecasts/targets for the FTV price?
Analysts Target Price 67.5 3.2%
Fortive (FTV) - Fundamental Data Overview as of 17 November 2026
Market Cap USD = 20.2b (20.2b USD * 1.0 USD.USD)
P/E Trailing = 32.1896
P/E Forward = 20.5761
P/S = 4.5985
P/B = 3.3992
P/EG = 1.2896
Revenue TTM = 4.40b USD
EBIT TTM = 874.2m USD
EBITDA TTM = 1.32b USD
Long Term Debt = 3.51b USD (from longTermDebt, last quarter)
Short Term Debt = 899.5m USD (from shortTermDebt, last fiscal year)
Debt = 3.61b USD (from shortLongTermDebtTotal, last quarter) + Leases 100.6m
Net Debt = 3.24b USD (calculated: Debt 3.61b - CCE 377.3m)
Enterprise Value = 23.5b USD (20.2b + Debt 3.61b - CCE 377.3m)
Interest Coverage Ratio = 6.39 (Ebit TTM 874.2m / Interest Expense TTM 136.8m)
EV/FCF = 21.61x (Enterprise Value 23.5b / FCF TTM 1.09b)
FCF Yield = 4.63% (FCF TTM 1.09b / Enterprise Value 23.5b)
FCF Margin = 24.69% (FCF TTM 1.09b / Revenue TTM 4.40b)
Net Margin = 14.83% (Net Income TTM 651.9m / Revenue TTM 4.40b)
Gross Margin = 63.47% ((Revenue TTM 4.40b - Cost of Revenue TTM 1.61b) / Revenue TTM)
Gross Margin QoQ = 64.16% (prev 63.39%)
Tobins Q-Ratio = 2.04 (Enterprise Value 23.5b / Total Assets 11.5b)
Interest Expense / Debt = 3.78% (Interest Expense 136.8m / Debt 3.61b)
Taxrate = 11.04% (81.6m / 739.3m)
NOPAT = 777.7m (EBIT 874.2m * (1 - 11.04%))
Current Ratio = 1.23 (Total Current Assets 1.58b / Total Current Liabilities 1.29b)
Debt / Equity = 0.61 (Debt 3.61b / totalStockholderEquity, last quarter 5.95b)
Debt / EBITDA = 2.44 (Net Debt 3.24b / EBITDA 1.32b)
Debt / FCF = 2.98 (Net Debt 3.24b / FCF TTM 1.09b)
Total Stockholder Equity = 6.14b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.57% (Net Income 651.9m / Total Assets 11.5b)
RoE = 10.62% (Net Income TTM 651.9m / Total Stockholder Equity 6.14b)
RoCE = 9.06% (EBIT 874.2m / Capital Employed (Equity 6.14b + L.T.Debt 3.51b))
RoIC = 7.14% (NOPAT 777.7m / Invested Capital 10.9b)
WACC = 7.61% (E(20.2b)/V(23.8b) * Re(8.37%) + D(3.61b)/V(23.8b) * Rd(3.78%) * (1-Tc(0.11)))
Discount Rate = 8.37% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -97.98 | Cagr: -6.65%
[DCF] Terminal Value 74.99% ; FCFF base≈1.10b ; Y1≈1.07b ; Y5≈1.08b
[DCF] Fair Price = 45.74 (EV 16.9b - Net Debt 3.24b = Equity 13.6b / Shares 297.6m; r=8.35% [WACC [floored]]; 5y FCF grow -3.27% → 2.50% )
EPS Correlation: -68.25 | EPS CAGR: -7.64% | SUE: 1.86 | # QB: 1
Revenue Correlation: -86.14 | Revenue CAGR: -12.77% | SUE: 0.10 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.76 | Chg30d=+0.77% | Revisions=+29% | Analysts=10
EPS current Year (2026-12-31): EPS=3.12 | Chg30d=+3.46% | Revisions=+77% | GrowthEPS=+15.1% | GrowthRev=+6.7%
EPS next Year (2027-12-31): EPS=3.32 | Chg30d=+2.15% | Revisions=+62% | GrowthEPS=+6.5% | GrowthRev=+3.7%
[Analyst] Revisions Ratio: +74% (up=22, down=2)